Table 5.
Risk of metabolic syndrome in men and women according to the quartiles of serum 25‐hydroxyvitamin D levels
Quartiles of 25‐(OH)D in men | ||||
---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |
Cut‐off points | ≤12.08 | 12.08–16.65 | 16.66–22.90 | ≥22.91 |
Model 1 | 1.000 (ref.) | 0.93 (0.55–1.58) | 0.87 (0.50–1.52) | 0.51 (0.30–0.88)* |
Model 2 | 1.000 (ref.) | 0.90 (0.53–1.53) | 0.86 (0.49–1.51) | 0.50 (0.29–0.87)* |
Model 3 | 1.000 (ref.) | 0.93 (0.54–1.59) | 0.89 (0.50–1.56) | 0.48 (0.28–0.84)* |
Quartiles of 25‐(OH)D in women | ||||
---|---|---|---|---|
Cut‐off points | ≤8.60 | 8.61–12.34 | 12.35–16.91 | ≥16.92 |
Model 1 | 1.000 (ref.) | 0.68 (0.45–1.02) | 0.55 (0.35–0.87)* | 0.98 (0.63–1.51) |
Model 2 | 1.000 (ref.) | 0.68 (0.45–1.02) | 0.56 (0.35–0.89)* | 0.98 (0.63–1.53) |
Model 3 | 1.000 (ref.) | 1.04 (0.66–1.63) | 0.71 (0.43–1.16) | 0.58 (0.34–0.99)* |
Model 1: unadjusted. Model 2: adjusted for age, cigarette smoking status, alcohol consumption and physical activity. Model 3: adjusted for the above plus total serum cholesterol, low‐density lipoprotein cholesterol and creatinine. *P < 0.05. 25‐(OH)D, 25‐hydroxyvitamin D.